Joan Malcolm, PhD, MBA, serves as Chief Commercial Officer at Clairity, where she leads commercial strategy, market access, and strategic partnerships. Her work is focused on one goal: expanding access to personalized breast cancer risk assessment for women around the world. 

Prior to joining Clairity, Joan served as Vice President of Market Access and Partnerships at GRAIL, where she built the commercial foundation for a first-in-class cancer screening category—translating early clinical innovation into scalable partnerships across health systems, payers, employers, and provider organizations. Before GRAIL, she held a series of leadership roles at The Jackson Laboratory, helping build and launch innovative genomics and precision medicine businesses. 

Joan holds an MBA from the Haas School of Business at the University of California, Berkeley, a PhD in Biomedical Sciences and Engineering from the University of Maine/The Jackson Laboratory, and a BS in Biological Engineering from the University of Maine. 

At Clairity, Joan is focused on building the partnerships that will help make AI-enabled, personalized breast cancer risk assessment a standard part of care for women everywhere.